Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT IV: Edifoligide for Prevention of Vein Graft Failure in CABG
NCT00042081Phase 3Completed
- Sponsor
- Anesiva
- Start
- Jul 2002
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary artery disease (CAD) comparing CGT003 Arm with Placebo Arm (2 arms). Primary endpoint: Vein Graft Failure. Started Jul 2002; status: completed.
02
Drugs
edifoligide
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00042081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042081.